Group One Trading’s Hepion Pharmaceuticals HEPA Stock Holding History

Group One Trading’s Portfolio HEPA Stock Details HEPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2	Closed	-$570	–	7495
2022 Q4	$570	Sell	2 -2	-50%	-$845	﹤0.01%	6926
2022 Q3	$2K	Hold	4	–	–	﹤0.01%	7151
2022 Q2	$2K	Sell	4 -26	-87%	-$21.6K	﹤0.01%	7406
2022 Q1	$39K	Sell	30 -9	-23%	-$9.95K	﹤0.01%	6293
2021 Q4	$44K	Sell	39 -6	-13%	-$8.22K	﹤0.01%	6436
2021 Q3	$69K	Sell	45 -36	-44%	-$57.6K	﹤0.01%	6274
2021 Q2	$161K	Sell	81 -26	-24%	-$47.6K	﹤0.01%	5465
2021 Q1	$197K	Buy	+107	New	+$235K	﹤0.01%	5043

Other funds holding HEPA

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's HEPA Position: Q2 2025 in Review

Group One Trading sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 4 shares — an estimated $2 sold.

Group One Trading first reported a position in HEPA in Q4 2020 and held it in 18 quarters. The position peaked at $195K in Q1 2021. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.

Group One Trading reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Group One Trading sold 4 Hepion Pharmaceuticals shares in Q2 2025, an estimated $2.
Group One Trading first reported a position in Hepion Pharmaceuticals in Q4 2020 and held it in 18 quarters.
Group One Trading's Hepion Pharmaceuticals position peaked at $195K in Q1 2021.
4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.